Todd C. Brady - Sep 7, 2023 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
President and CEO, Director
Signature
/s/ Todd C. Brady
Stock symbol
ALDX
Transactions as of
Sep 7, 2023
Transactions value $
-$382,159
Form type
4
Date filed
9/11/2023, 05:42 PM
Previous filing
May 11, 2023
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALDX Common Stock Options Exercise $106K +192K +13.2% $0.55* 1.65M Sep 7, 2023 Direct
transaction ALDX Common Stock Options Exercise $18.2K +33K +2% $0.55* 1.68M Sep 7, 2023 Direct
transaction ALDX Common Stock Options Exercise $26.5K +48K +2.86% $0.55* 1.73M Sep 7, 2023 Direct
transaction ALDX Common Stock Tax liability -$533K -73.8K -4.27% $7.22 1.65M Sep 7, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (right to buy) Options Exercise $0 -192K -100% $0.00* 0 Sep 7, 2023 Common Stock 192K $0.55 Direct F2
transaction ALDX Stock Option (right to buy) Options Exercise $0 -33K -100% $0.00* 0 Sep 7, 2023 Common Stock 33K $0.55 Direct F2
transaction ALDX Stock Option (right to buy) Options Exercise $0 -48K -100% $0.00* 0 Sep 7, 2023 Common Stock 48K $0.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the exercise of the stock options.
F2 The stock option is fully vested.